Centre for Biomedical Engineering, Indian Institute of Technology Delhi, Hauz Khas, New Delhi-110016, India.
Department of Molecular and Cellular Medicine, Institute of Liver and Biliary Sciences, D1, Vasant Kunj Marg, New Delhi, Delhi 110070, India.
J Mater Chem B. 2024 Jan 17;12(3):772-783. doi: 10.1039/d3tb01652h.
The development of liver scaffolds retaining their three-dimensional (3D) structure and extra-cellular matrix (ECM) composition is essential for the advancement of liver tissue engineering. We report the design and validation of an alginate-based platform using a combination of decellularized matrices and collagen to preserve the functionality of liver cells. The scaffolds were characterized using SEM and fluorescence microscopy techniques. The proliferation and functional behaviours of hepatocellular carcinoma HuH7 cells were observed. It was found that the decellularized skin scaffold with collagen was better for maintaining the growth of cells in comparison to other decellularized matrices. In addition, we observed a significant increase in the functional profile once exogenous collagen was added to the liver matrix. Our study also suggests that a cirrhotic liver model should have a different matrix composition as compared to a healthy liver model. When primary rat hepatocytes were used for developing a healthy liver model, the proliferation studies with hepatocytes showed a decellularized skin matrix as the better option, but the functionality was only maintained in a decellularized liver matrix with addition of exogenous collagen. We further checked if these platforms can be used for studying drug induced toxicity observed in the liver by studying the activation of cytochrome P450 upon drug exposure of the cells growing in our model. We observed a significant induction of the CYP1A1 gene on administering the drugs for 6 days. Thus, this platform could be used for drug-toxicity screening studies using primary hepatocytes in a short span of time. Being a microscaffold based system, this platform offers some advantages, such as smaller volumes of samples, analysing multiple samples simultaneously and a minimal amount of decellularized matrix in the matrix composition, making it an economical option compared to a completely dECM based platform.
为了推进肝脏组织工程学的发展,开发保留其三维(3D)结构和细胞外基质(ECM)组成的肝脏支架至关重要。我们报告了一种使用脱细胞基质和胶原蛋白组合来保留肝细胞功能的基于藻酸盐的平台的设计和验证。使用 SEM 和荧光显微镜技术对支架进行了表征。观察了肝癌 HuH7 细胞的增殖和功能行为。结果发现,与其他脱细胞基质相比,具有胶原蛋白的脱细胞皮肤支架更有利于维持细胞的生长。此外,我们观察到一旦向肝基质中添加外源性胶原蛋白,功能谱就会显著增加。我们的研究还表明,与健康肝模型相比,肝硬化肝模型应具有不同的基质组成。当使用原代大鼠肝细胞开发健康肝模型时,用肝细胞进行的增殖研究表明脱细胞皮肤基质是更好的选择,但仅在外源性胶原蛋白添加到脱细胞肝基质中才能维持功能。我们进一步检查了这些平台是否可以用于研究通过研究细胞在我们的模型中生长时暴露于药物后细胞色素 P450 的激活来观察到的肝脏中药物诱导的毒性。我们观察到在给药 6 天后 CYP1A1 基因显著诱导。因此,该平台可用于使用原代肝细胞在短时间内进行药物毒性筛选研究。作为基于微支架的系统,该平台具有一些优势,例如样品体积较小,同时分析多个样品,以及在基质组成中使用最少量的脱细胞基质,与完全基于 dECM 的平台相比,这是一种经济的选择。